SK1462003A3 - Tartrate salt of thiazolidinedione derivative - Google Patents

Tartrate salt of thiazolidinedione derivative Download PDF

Info

Publication number
SK1462003A3
SK1462003A3 SK146-2003A SK1462003A SK1462003A3 SK 1462003 A3 SK1462003 A3 SK 1462003A3 SK 1462003 A SK1462003 A SK 1462003A SK 1462003 A3 SK1462003 A3 SK 1462003A3
Authority
SK
Slovakia
Prior art keywords
tartrate
solvate
compound
heat
dione
Prior art date
Application number
SK146-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK1462003A3 publication Critical patent/SK1462003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Cosmetics (AREA)
SK146-2003A 2000-08-04 2001-08-03 Tartrate salt of thiazolidinedione derivative SK1462003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019224.5A GB0019224D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003511 WO2002012232A1 (fr) 2000-08-04 2001-08-03 Tartrate de derive de thiazolidinedione

Publications (1)

Publication Number Publication Date
SK1462003A3 true SK1462003A3 (en) 2004-06-08

Family

ID=9897026

Family Applications (1)

Application Number Title Priority Date Filing Date
SK146-2003A SK1462003A3 (en) 2000-08-04 2001-08-03 Tartrate salt of thiazolidinedione derivative

Country Status (36)

Country Link
US (1) US20040014790A1 (fr)
EP (1) EP1305311B1 (fr)
JP (1) JP2004505970A (fr)
KR (1) KR100755174B1 (fr)
CN (1) CN1455778A (fr)
AP (1) AP1785A (fr)
AT (1) ATE384059T1 (fr)
AU (1) AU2001276506A1 (fr)
BG (1) BG107604A (fr)
BR (1) BR0112982A (fr)
CA (1) CA2417827A1 (fr)
CY (1) CY1107252T1 (fr)
CZ (1) CZ2003313A3 (fr)
DE (1) DE60132461T2 (fr)
DK (1) DK1305311T3 (fr)
DZ (1) DZ3418A1 (fr)
EA (1) EA005408B1 (fr)
EC (1) ECSP034467A (fr)
ES (1) ES2296772T3 (fr)
GB (1) GB0019224D0 (fr)
HR (1) HRP20030068B1 (fr)
HU (1) HUP0300778A3 (fr)
IL (2) IL154275A0 (fr)
MA (1) MA25832A1 (fr)
MX (1) MXPA03001085A (fr)
NO (1) NO324596B1 (fr)
NZ (1) NZ524030A (fr)
OA (1) OA12354A (fr)
PL (1) PL360662A1 (fr)
PT (1) PT1305311E (fr)
SI (1) SI1305311T1 (fr)
SK (1) SK1462003A3 (fr)
UA (1) UA76720C2 (fr)
WO (1) WO2002012232A1 (fr)
YU (1) YU14603A (fr)
ZA (1) ZA200300961B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
EP3367946B1 (fr) 2015-10-27 2020-07-08 Nanopass Technologies Ltd. Dispositif à micro-aiguilles avec guide mécanique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
EA005408B1 (ru) 2005-02-24
ES2296772T3 (es) 2008-05-01
KR100755174B1 (ko) 2007-09-03
NZ524030A (en) 2004-07-30
EP1305311A1 (fr) 2003-05-02
CZ2003313A3 (cs) 2004-02-18
HRP20030068A2 (en) 2005-02-28
US20040014790A1 (en) 2004-01-22
YU14603A (sh) 2006-05-25
DZ3418A1 (fr) 2002-02-14
NO20030530L (no) 2003-02-03
MXPA03001085A (es) 2003-05-27
NO20030530D0 (no) 2003-02-03
HUP0300778A3 (en) 2005-04-28
MA25832A1 (fr) 2003-07-01
EP1305311B1 (fr) 2008-01-16
DE60132461T2 (de) 2008-12-24
AU2001276506A1 (en) 2002-02-18
CA2417827A1 (fr) 2002-02-14
PL360662A1 (en) 2004-09-20
HUP0300778A2 (hu) 2003-11-28
HRP20030068B1 (en) 2008-07-31
PT1305311E (pt) 2008-04-07
DK1305311T3 (da) 2008-05-19
CN1455778A (zh) 2003-11-12
EA200300230A1 (ru) 2003-06-26
OA12354A (en) 2004-03-19
IL154275A (en) 2009-02-11
WO2002012232A1 (fr) 2002-02-14
GB0019224D0 (en) 2000-09-27
DE60132461D1 (de) 2008-03-06
IL154275A0 (en) 2003-09-17
BG107604A (bg) 2003-09-30
ZA200300961B (en) 2004-04-01
HK1057358A1 (en) 2004-04-02
AP1785A (en) 2007-10-04
CY1107252T1 (el) 2012-11-21
ATE384059T1 (de) 2008-02-15
BR0112982A (pt) 2003-08-26
KR20030022355A (ko) 2003-03-15
SI1305311T1 (sl) 2008-04-30
AP2003002736A0 (en) 2003-03-31
JP2004505970A (ja) 2004-02-26
UA76720C2 (uk) 2006-09-15
NO324596B1 (no) 2007-11-26
ECSP034467A (es) 2003-03-31

Similar Documents

Publication Publication Date Title
SK1442003A3 (en) Tartrate salts of thiazolidinedione derivative
BG107607A (bg) Хидрохлоридна сол на 5-[4-[2-(n-метил-n-(2-пиридил)амино)етокси]бензил]тиазолидин-2,4-дион
EP1305311B1 (fr) Tartrate de derive de thiazolidinedione
SK1452003A3 (en) Tartrate salts of thiazolidinedione derivative
AU2001292028B2 (en) Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione
SK1432003A3 (en) Tartrate salts of thiazolidinedione derivative
CN1620453B (zh) 噻唑烷二酮衍生物及其作为抗糖尿病药的用途
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
SK17152002A3 (sk) Hydrojodid 5-[4-[2-(N-metyl-N-(2-pyridyl)amíno)etoxy]- benzyl]tiazolidín-2,4-diónu ako liečivo
HK1057358B (en) Tartrate salt of thiazolidinedione derivative
AU2005229694A1 (en) Tartrate salt of thiazolidinedione derivative

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure